Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trypsin, Bromelain and Rutoside Combination for Pain in Symptomatic Irreversible Pulpitis
NCT06298383Completed
- Sponsor
- Cairo University
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Replacement Enzymes, Covalent Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of trypsin, bromelain and rutin in irreversible pulpitis (4 arms), sponsored by Cairo University. Primary endpoints: Success of Anesthesia and Post-operative pain at 1 week. Started Jun 2025; status: completed.
02
Drugs
trypsinbromelainrutin
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06298383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06298383.